So-Young International Inc. logo

So-Young International Inc.

SY

NASDAQHealthcareMedical - Healthcare Information Services

Previous close

$2.29

+$0.02 · +0.88%

Aug 21, 4:00 PM ET

SY company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

47

Fair Value

Momentum

16

Strong Down

Sentiment

39

Bearish

Risk resilience

22

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

So-Young International Inc. manages a digital platform specializing in medical aesthetics and elective healthcare services, serving customers in the People's Republic of China and globally. This online ecosystem enables users to explore content, share personal experiences regarding medical aesthetic procedures, and book in-person treatments with various medical aesthetic service providers. The platform also offers resources for researching treatment trends, features ratings and reviews of treatment experiences, and publishes blogs under headings like "Beauty Diaries." Beyond cosmetic enhancements, So-Young facilitates reservations for a broader spectrum of healthcare needs, including dermatology, dentistry (with orthodontics), ophthalmology, comprehensive physical examinations, gynecology, human papillomavirus vaccinations, and postnatal support. The company also supplies Software-as-a-Service (SaaS) solutions and provides guidance and training programs to medical service providers. Its offerings extend to internet information and technology advisory, management consulting, and internet culture services. Furthermore, So-Young is involved in the sale of medical equipment, equipment manufacturing, sales, and agency services, as well as microfinance. As of December 31, 2021, its platform had established connections with approximately 8,400 medical aesthetic service providers and an additional 5,000 providers offering other consumption-focused healthcare services. Established in 2013, So-Young International Inc. maintains its corporate headquarters in Beijing, China.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
CN
CEO
Xing Jin
Listed since
May 2, 2019
Employees
2,348

Market position

Day range

Current $2.29

52-week range

Current $2.29

Open
$2.30
Previous close
$2.27
Volume
314.19K
0.68× average
Average volume
462.27K
Average daily volume
Market cap
300.47M USD
Beta
2.06
Market reference 1
50-day average
$1.8401
+24.45% above average
200-day average
$2.6549
-13.74% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.17B CNY
EV / EBITDA
-11.92×
Earnings yield
-10.01%
Free cash flow yield
-12.82%

Profitability & efficiency

Return on equity
-15.16%
Return on assets
-8.89%
Return on invested capital
-13.03%

Financial health

Current ratio
1.89×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends93%44%-6%-55%Gross margin, FY2021: 80.63%Gross margin, FY2022: 68.73%Gross margin, FY2023: 63.66%Gross margin, FY2024: 61.30%Gross margin, FY2025: 47.77%Operating margin, FY2021: -1.92%Operating margin, FY2022: -8.17%Operating margin, FY2023: -4.08%Operating margin, FY2024: -42.58%Operating margin, FY2025: -17.49%Net margin, FY2021: -0.49%Net margin, FY2022: -5.21%Net margin, FY2023: 1.42%Net margin, FY2024: -40.19%Net margin, FY2025: -15.91%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 80.63%. Gross margin FY2022 68.73%. Gross margin FY2023 63.66%. Gross margin FY2024 61.30%. Gross margin FY2025 47.77%. Operating margin FY2021 -1.92%. Operating margin FY2022 -8.17%. Operating margin FY2023 -4.08%. Operating margin FY2024 -42.58%. Operating margin FY2025 -17.49%. Net margin FY2021 -0.49%. Net margin FY2022 -5.21%. Net margin FY2023 1.42%. Net margin FY2024 -40.19%. Net margin FY2025 -15.91%.

Income trends

Revenue

1.48B CNY+1.04%

Operating income

−259.21M CNY+58.49%

Net income

−235.7M CNY+60.02%
Income trends across reported periods1.92B CNY997.38M CNY70.59M CNY−856.19M CNYRevenue, FY2021: 1.69B CNYRevenue, FY2022: 1.26B CNYRevenue, FY2023: 1.5B CNYRevenue, FY2024: 1.47B CNYRevenue, FY2025: 1.48B CNYOperating income, FY2021: −32.57M CNYOperating income, FY2022: −102.81M CNYOperating income, FY2023: −61.05M CNYOperating income, FY2024: −624.49M CNYOperating income, FY2025: −259.21M CNYNet income, FY2021: −8.37M CNYNet income, FY2022: −65.55M CNYNet income, FY2023: 21.28M CNYNet income, FY2024: −589.53M CNYNet income, FY2025: −235.7M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.69B CNY. Revenue FY2022 1.26B CNY. Revenue FY2023 1.5B CNY. Revenue FY2024 1.47B CNY. Revenue FY2025 1.48B CNY. Operating income FY2021 −32.57M CNY. Operating income FY2022 −102.81M CNY. Operating income FY2023 −61.05M CNY. Operating income FY2024 −624.49M CNY. Operating income FY2025 −259.21M CNY. Net income FY2021 −8.37M CNY. Net income FY2022 −65.55M CNY. Net income FY2023 21.28M CNY. Net income FY2024 −589.53M CNY. Net income FY2025 −235.7M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue1.48B CNY1.47B CNY1.5B CNY1.26B CNY1.69B CNY
Cost of goods sold774.04M CNY567.59M CNY544.34M CNY393.29M CNY327.89M CNY
Gross profit707.86M CNY899.11M CNY953.69M CNY864.58M CNY1.36B CNY
Research and development133.31M CNY165.03M CNY203.52M CNY235.09M CNY286.57M CNY
Selling, general, and administrative833.76M CNY818.57M CNY811.22M CNY732.3M CNY1.04B CNY
Operating expenses967.07M CNY1.52B CNY1.01B CNY967.39M CNY1.4B CNY
Interest income24.6M CNY46.51M CNY48.84M CNY28.88M CNY19.33M CNY
Depreciation and amortization57.21M CNY46.09M CNY46.09M CNY47.09M CNY30.08M CNY
Operating income−259.21M CNY−624.49M CNY−61.05M CNY−102.81M CNY−32.57M CNY
Net income−235.7M CNY−589.53M CNY21.28M CNY−65.55M CNY−8.37M CNY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
50%
5 beats, 5 misses, 0 met estimates
Average EPS surprise
+94.45%
10 comparable reports
Latest EPS result
-0.07
Estimate -0.1 · Beat by 33.25%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.05-0.02-0.1-0.17Q1 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26EstimateQ4 '26Estimate
Q1 2025, reported Mar 28, 2025: actual -0.07, estimate 0.012, surprise -682.85%, Miss. Q2 2025, reported May 16, 2025: actual -0.04, estimate -0.047, surprise +15.47%, Beat. Q3 2025, reported Aug 15, 2025: actual -0.04, estimate -0.015, surprise -166.67%, Miss. Q4 2025, reported Nov 17, 2025: actual -0.09, estimate -0.047, surprise -92.97%, Miss. Q1 2026, reported Mar 25, 2026: actual -0.13, estimate -0.097, surprise -33.46%, Miss. Q2 2026, reported May 22, 2026: actual -0.07, estimate -0.105, surprise +33.25%, Beat. Q3 2026, reported Aug 31, 2026: actual —, estimate -0.088, surprise —, Comparison unavailable. Q4 2026, reported Nov 23, 2026: actual —, estimate -0.076, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates80.71M66.26M51.81M37.36MQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26EstimateQ4 '26Estimate
Q1 2025, reported Mar 28, 2025: actual 50.57M USD, estimate 55.14M USD, surprise -8.29%, Miss. Q2 2025, reported May 16, 2025: actual 40.95M USD, estimate 40.47M USD, surprise +1.20%, Beat. Q3 2025, reported Aug 15, 2025: actual 52.85M USD, estimate 50.55M USD, surprise +4.56%, Beat. Q4 2025, reported Nov 17, 2025: actual 54.3M USD, estimate 54.3M USD, surprise +0.01%, Beat. Q1 2026, reported Mar 25, 2026: actual 65.86M USD, estimate 62.42M USD, surprise +5.51%, Beat. Q2 2026, reported May 22, 2026: actual 62.72M USD, estimate 60.2M USD, surprise +4.19%, Beat. Q3 2026, reported Aug 31, 2026: actual —, estimate 70.4M USD, surprise —, Comparison unavailable. Q4 2026, reported Nov 23, 2026: actual —, estimate 77.61M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$0.80

65.07% downside
Past 12 months12-month forecastHigh $0.80Average $0.80Low $0.80

SY peers

ETFs holding SY

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research SY

research.disclaimer